Michael W. Nall
2020
In 2020, Michael W. Nall earned a total compensation of $1.8M as President and Chief Executive Officer at Biocept, a 47% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $235,125 |
|---|---|
| Option Awards | $1,043,830 |
| Salary | $495,000 |
| Other | $9,450 |
| Total | $1,783,405 |
Nall received $1M in option awards, accounting for 59% of the total pay in 2020.
Nall also received $235.1K in non-equity incentive plan, $495K in salary and $9.5K in other compensation.
Rankings
In 2020, Michael W. Nall's compensation ranked 6,048th out of 13,090 executives tracked by ExecPay. In other words, Nall earned more than 53.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,048 out of 13,090 | 54th |
Division Services | 1,221 out of 2,338 | 48th |
Major group Health Services | 127 out of 252 | 50th |
Industry group Medical And Dental Laboratories | 38 out of 73 | 48th |
Industry Medical Laboratories | 38 out of 73 | 48th |
Source: SEC filing on April 30, 2021.
Nall's colleagues
We found two more compensation records of executives who worked with Michael W. Nall at Biocept in 2020.